Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Biosimilars for Management of Crohn Disease

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Patent Foramen Ovale: A Villain in Pulmonary Embolism?

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Comparison of Five Major Guidelines for Statin Use in Primary Prevention in a Contemporary General Population

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Managing vitamin D deficiency in inflammatory bowel disease

    Research output: Contribution to journalReviewResearchpeer-review

  2. Metabonomics in Gastroenterology and Hepatology

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Fluorescence-based tracing of transplanted intestinal epithelial cells using confocal laser endomicroscopy

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Methotrexate for inflammatory bowel disease: time for reconsideration

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Original languageEnglish
JournalAnnals of Internal Medicine
Volume170
Issue number2
Pages (from-to)129-130
Number of pages2
ISSN0003-4819
DOIs
Publication statusPublished - 15 Jan 2019

    Research areas

  • Biosimilar Pharmaceuticals/economics, Cost Savings, Crohn Disease/drug therapy, Drug Development/economics, European Union, Humans, Infliximab/therapeutic use, Prescription Fees, Tumor Necrosis Factor-alpha/antagonists & inhibitors, United States

ID: 59003444